Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
Joint Authors
Culican, Susan M.
Kraus, Courtney L.
Source
International Journal of Rheumatology
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-12-15
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Biologic agents have dramatically shifted the treatment paradigm for rheumatic disease.
Use of these agents can decrease disease burden, allow the patient to be weaned from corticosteroids, and reduce the likelihood of relapse.
Eye disease associated with rheumatic conditions may present with a wide range of signs and symptoms.
This coexisting pathology should not be overlooked and should be considered a reason for initiation or continuation of biologic therapy.
Additionally, many of the ocular manifestations of rheumatic disease respond preferentially to specific targeting molecules.
This paper summarizes the available studies on the use, efficacy, and safety of biologic agents in the treatment of ocular manifestations of rheumatic disease.
American Psychological Association (APA)
Kraus, Courtney L.& Culican, Susan M.. 2011. Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease. International Journal of Rheumatology،Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-454199
Modern Language Association (MLA)
Kraus, Courtney L.& Culican, Susan M.. Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease. International Journal of Rheumatology No. 2012 (2012), pp.1-6.
https://search.emarefa.net/detail/BIM-454199
American Medical Association (AMA)
Kraus, Courtney L.& Culican, Susan M.. Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease. International Journal of Rheumatology. 2011. Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-454199
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-454199